Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
AVDL
#1632
Avadel Pharmaceuticals plc
21.640
0
+0.05%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+0.05%
Aylık değişim
+0.70%
6 aylık değişim
+16.66%
Yıllık değişim
+16.66%
Önceki kapanış
21.630
0
Open
21.640
0
Bid
Ask
Low
21.640
0
High
21.640
0
Hacim
1 054
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
AVDL
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
96.36 M
96.63 M
96.74 M
97.1 M
97.66 M
—
Valuation ratios
Enterprise value
1.24 B
964.2 M
701.1 M
795.91 M
1.41 B
3.87 B
Price to earnings ratio
-17.49
-20.61
-30.12
-442.5
1 527
1 033.78
Price to sales ratio
8.8
5.91
3.87
3.88
6.05
19.71
Price to cash flow ratio
14.04
21.32
29.75
245.86
83.12
380.06
Price to book ratio
3.8
13.54
2.57
2.74
4.45
23.3
Enterprise value to EBITDA ratio
-19.3
-22.81
—
—
—
—
Profitability ratios
Return on assets %
-0.02
-0.03
-0.03
-0
-0.05
-0.11
Return on equity %
-0.04
-0.07
-0.07
-0
-0.1
-0.24
Return on invested capital %
3.1
-27.86
-25.15
11.86
-11.6
-52.75
Gross margin %
87.7
90.45
89.38
90.66
105.31
375.8
Operating margin %
0.65
-6.54
-5.71
4.23
-5.25
-13.27
EBITDA margin %
-0.65
-6.54
—
—
—
—
Net margin %
-5.25
-10
-9.37
-0.26
-12.68
-32.31
Liquidity ratios
Quick ratio
2.6
2.33
2.33
2.38
2.37
9.42
Current ratio
2.97
2.75
2.73
2.79
2.76
11.03
Inventory turnover
0.42
0.26
0.27
0.29
-0.17
0.65
Asset turnover
0.32
0.31
0.32
0.38
0.4
1.41
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.07
0.08
-0.09
0.13
0.22
0.35
EBIT per share
-0
-0.03
-0.03
0.09
0.02
0.04
EBITDA per share
-0
-0.03
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.69
0.78
0.69
0.82
0.92
3.21
Net current asset value per share
1.34
1.41
1.44
1.61
1.73
6.19
Tangible book value per share
0.61
0.6
0.59
0.75
0.82
2.75
Working capital per share
0.89
0.9
0.91
1.03
1.1
3.94
Book value per share
0.79
0.78
0.77
0.92
0.98
3.44
Haberler
I risultati di Alkermes in arrivo mentre prende forma la strategia sul sonno
Alkermes earnings up next as sleep strategy takes shape
Harmony Biosciences Makes The Grade (NASDAQ:HRMY)
Obiettivo di prezzo di Alkermes alzato a $47 da $46 da UBS dopo l’accordo con Avadel
Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal
BlackRock rivela una partecipazione del 6,94% in Avadel Pharmaceuticals
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals
TIG Advisors rivela una partecipazione del 4,18% in Avadel Pharmaceuticals
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals
Goldman Sachs rivela posizione di trading in Avadel Pharmaceuticals
Goldman Sachs discloses trading position in Avadel Pharmaceuticals
Janus Henderson rivela una partecipazione dell’1,87% in Avadel Pharmaceuticals